Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Sun Pharma Recalls 400,000 Bottles of Drugs in U.S., FDA Says

May 8 (Bloomberg) -- Sun Pharmaceutical Industries Ltd., India’s largest drugmaker by market value, is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the U.S. because the pills failed to dissolve properly.

The recall is the latest in a string by Indian companies that has led to increased scrutiny from regulators concerned that the quality of drugs made in that country aren’t up to U.S. standards. The concerns prompted Margaret Hamburg, the commissioner of the U.S. Food and Drug Administration, to go to India in February to meet with pharmaceutical makers there about production quality.

About 128,000 bottles of Sun Pharma’s Cetirizine, the antihistamine, “may not meet the drug release specification through expiry,” the FDA said in a statement. The 252,000 bottles of generic Effexor, called Venlafaxine, for depression being recalled are distributed by Sun’s U.S. arm, Caraco Pharmaceutical Laboratories Ltd., and are manufactured in Gujarat, India.

To contact the reporter on this story: Sonali Basak in New York at sbasak7@bloomberg.net

To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net Bruce Rule

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.